New chair Daniel Brat, MD, PhD, is spearheading transformations in pathology, a field that’s rapidly evolving in parallel with advances in precision medicine and a trend toward sub-specialization.
Scientists found more than 100 possible cancer-causing mutations and defective alleles in a large-scale genetic analysis of pediatric cancers that was co-authored by Elizabeth Perlman, MD, and published in Nature.
Patients with advanced prostate cancer who received more intensive treatment experienced worse quality of life at three months, but better overall in the long-term, according to a new Northwestern Medicine study.
A drug called dasatinib was found to be safe and effective for children with chronic myeloid leukemia, according to a study published in the Journal of Clinical Oncology.
Among patients with stage III colon cancer, regular nut consumption was associated with significantly lower rates of cancer recurrence and death, according to a new study.
A new study has found that obese patients with metastatic melanoma live significantly longer than those with a normal body mass index — especially male patients treated with targeted or immune therapy.
Physicians and scientists in the Lurie Cancer Center’s OncoSET program are teaming up to help pioneer precision oncology.
Deputy Director Maha Hussain, MD oversees clinical research at the Lurie Cancer Center, but never forgets her primary goal: having an impact on patients.
Scientists have developed software that can forecast the survival of patients diagnosed with glioma that is more accurate than physicians’ predictions.
Maha Hussain, MD, recently published several papers detailing new findings in metastatic castration-resistant prostate cancer treatment and prostate cancer screening.